Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 103 Lung Neoplasms 49 Ovarian Neoplasms 44 Breast Neoplasms 31 Small Cell Lung Carcinoma 25 Neoplasms 20 Fallopian Tube Neoplasms 16 Triple Negative Breast Neoplasms 14 Carcinoma, Ovarian Epithelial 14 Neoplasm Metastasis 12 Adenocarcinoma of Lung 11 Uterine Cervical Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Lymphoma, Large B-Cell, Diffuse 8 Lymphoma, Non-Hodgkin 7 Lymphoma 7 Head and Neck Neoplasms 7 Carcinoma 7 Urinary Bladder Neoplasms 6 Esophageal Neoplasms 6 Endometrial Neoplasms 6 Brain Neoplasms 6 Thoracic Neoplasms 5 Prostatic Neoplasms 5 Melanoma 5 Lung Diseases 5 Adenocarcinoma Of Esophagus 5 Adenocarcinoma 5 Respiratory Tract Neoplasms 4 Recurrence 4

Interventions

Paclitaxel 1 NVP-BKM120 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Non-Small Cell Lunch Cancer × Carboplatin × Clear all

NCT01820325 2018-10-11

BASALT-2

Novartis

Phase 1 Terminated

Non-Small Cell Lunch Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡